Most people in Ohio’s biomedical industry would’ve considered 2010 a good year if just one key thing happened — voters renewed the state’s $1.35 billion, 10-year Third Frontier program, which is designed to energize Ohio’s economy by investing in cutting-edge technology.
It happened. And elation ensued in board rooms, investors’ offices and research laboratories.
By a nearly two-to-one margin, voters approved Third Frontier with a $700 million, four-year extension that’ll keep it alive until at least 2016 — and beyond, the industry no doubt prays. From CEOs to scientists to venture capitalists, nearly everyone in the industry will tell you that Third Frontier has been absolutely critical to the success of Ohio’s growing biomedical industry, which now boasts more than 1,600 organizations with a combined payroll of nearly $4 billion, according to BioOhio.
To read the full, original article click on this link: Third Frontier renewal tops Ohio biomedical highlights in 2010 « MedCity News
Author:
